Cargando…

Analysis of Risk Factors and Protective Strategies for Tube Blockage in Patients with Drug-Induced Liver Failure Based on Artificial Liver Therapy

OBJECTIVE: To analyse the influencing factors of tube blockage during the treatment of artificial liver in patients with drug-induced liver failure and explore effective patient protection strategies. METHODS: In this study, 49 patients with pharmacological (antituberculosis drugs, antibiotics, prop...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yan, Shi, Liping, Deng, Luxi, Zhao, Xiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118878/
https://www.ncbi.nlm.nih.gov/pubmed/37089717
http://dx.doi.org/10.1155/2023/8201776
_version_ 1785028896510443520
author Shen, Yan
Shi, Liping
Deng, Luxi
Zhao, Xiaoling
author_facet Shen, Yan
Shi, Liping
Deng, Luxi
Zhao, Xiaoling
author_sort Shen, Yan
collection PubMed
description OBJECTIVE: To analyse the influencing factors of tube blockage during the treatment of artificial liver in patients with drug-induced liver failure and explore effective patient protection strategies. METHODS: In this study, 49 patients with pharmacological (antituberculosis drugs, antibiotics, proprietary Chinese medicine, gastric drugs, and antihyperthyroid drugs) liver failure admitted to our hospital from June 2015 to December 2021 were selected for prospective analysis. Clinical indicators and general data of all patients were collected and collated, risk factors leading to the obstruction of artificial liver treatment were analysed, and corresponding protective measures were proposed. RESULTS: The incidence of tube blockage was 5.32% (10 times) in 49 patients with pharmacological liver failure treated 188 times with artificial liver therapy. The incidence of tube blockage was significantly higher in patients in the PDF mode than in those in the PP and PE modes (P < 0.05), and there were differences in the location of blocked tubes between the treatment modes. Blocked tubes occurred more often in the venous cauldron of the circuit in the PDF mode and in the plasma separator of the circuit in the PP mode. The incidence of tube blockage was significantly lower in patients with no more than 3 treatments than in those with 3 to 5 treatments and those with more than 5 treatments (p < 0.05). The incidence of catheter blockage was higher in patients with PTA values ≤20% than in those with PTA values between 20% and 30%, and higher than in those with PTA values above 30% (P < 0.05). CONCLUSION: The risk factors of tube plugging in patients with liver failure treated with artificial liver include different treatment modes, different treatment times, and different PTA values. The PDF mode has a higher rate of tube plugging than PE or PP treatment modes. The more the number of treatment times and the lower the PTA value of patients, the more tube plugging is likely to occur.
format Online
Article
Text
id pubmed-10118878
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-101188782023-04-21 Analysis of Risk Factors and Protective Strategies for Tube Blockage in Patients with Drug-Induced Liver Failure Based on Artificial Liver Therapy Shen, Yan Shi, Liping Deng, Luxi Zhao, Xiaoling Evid Based Complement Alternat Med Research Article OBJECTIVE: To analyse the influencing factors of tube blockage during the treatment of artificial liver in patients with drug-induced liver failure and explore effective patient protection strategies. METHODS: In this study, 49 patients with pharmacological (antituberculosis drugs, antibiotics, proprietary Chinese medicine, gastric drugs, and antihyperthyroid drugs) liver failure admitted to our hospital from June 2015 to December 2021 were selected for prospective analysis. Clinical indicators and general data of all patients were collected and collated, risk factors leading to the obstruction of artificial liver treatment were analysed, and corresponding protective measures were proposed. RESULTS: The incidence of tube blockage was 5.32% (10 times) in 49 patients with pharmacological liver failure treated 188 times with artificial liver therapy. The incidence of tube blockage was significantly higher in patients in the PDF mode than in those in the PP and PE modes (P < 0.05), and there were differences in the location of blocked tubes between the treatment modes. Blocked tubes occurred more often in the venous cauldron of the circuit in the PDF mode and in the plasma separator of the circuit in the PP mode. The incidence of tube blockage was significantly lower in patients with no more than 3 treatments than in those with 3 to 5 treatments and those with more than 5 treatments (p < 0.05). The incidence of catheter blockage was higher in patients with PTA values ≤20% than in those with PTA values between 20% and 30%, and higher than in those with PTA values above 30% (P < 0.05). CONCLUSION: The risk factors of tube plugging in patients with liver failure treated with artificial liver include different treatment modes, different treatment times, and different PTA values. The PDF mode has a higher rate of tube plugging than PE or PP treatment modes. The more the number of treatment times and the lower the PTA value of patients, the more tube plugging is likely to occur. Hindawi 2023-04-08 /pmc/articles/PMC10118878/ /pubmed/37089717 http://dx.doi.org/10.1155/2023/8201776 Text en Copyright © 2023 Yan Shen et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shen, Yan
Shi, Liping
Deng, Luxi
Zhao, Xiaoling
Analysis of Risk Factors and Protective Strategies for Tube Blockage in Patients with Drug-Induced Liver Failure Based on Artificial Liver Therapy
title Analysis of Risk Factors and Protective Strategies for Tube Blockage in Patients with Drug-Induced Liver Failure Based on Artificial Liver Therapy
title_full Analysis of Risk Factors and Protective Strategies for Tube Blockage in Patients with Drug-Induced Liver Failure Based on Artificial Liver Therapy
title_fullStr Analysis of Risk Factors and Protective Strategies for Tube Blockage in Patients with Drug-Induced Liver Failure Based on Artificial Liver Therapy
title_full_unstemmed Analysis of Risk Factors and Protective Strategies for Tube Blockage in Patients with Drug-Induced Liver Failure Based on Artificial Liver Therapy
title_short Analysis of Risk Factors and Protective Strategies for Tube Blockage in Patients with Drug-Induced Liver Failure Based on Artificial Liver Therapy
title_sort analysis of risk factors and protective strategies for tube blockage in patients with drug-induced liver failure based on artificial liver therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118878/
https://www.ncbi.nlm.nih.gov/pubmed/37089717
http://dx.doi.org/10.1155/2023/8201776
work_keys_str_mv AT shenyan analysisofriskfactorsandprotectivestrategiesfortubeblockageinpatientswithdruginducedliverfailurebasedonartificiallivertherapy
AT shiliping analysisofriskfactorsandprotectivestrategiesfortubeblockageinpatientswithdruginducedliverfailurebasedonartificiallivertherapy
AT dengluxi analysisofriskfactorsandprotectivestrategiesfortubeblockageinpatientswithdruginducedliverfailurebasedonartificiallivertherapy
AT zhaoxiaoling analysisofriskfactorsandprotectivestrategiesfortubeblockageinpatientswithdruginducedliverfailurebasedonartificiallivertherapy